{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T07:45:23Z","timestamp":1793259923100,"version":"4.5.0"},"reference-count":0,"publisher":"International Institute of Anticancer Research","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CDP"],"published-print":{"date-parts":[[2023,9,1]]},"abstract":"<jats:p>Background\/Aim: The plasma levels of cell-free DNA (cfDNA) in cancer patients increase due to rapid cancer cell proliferation and death. Therefore, cfDNA can be used to study specific tumor-DNA features. In addition, the non-specific cfDNA concentration may be an important biomarker of cancer prognosis. Patients and Methods: We prospectively examined the predictive role of cfDNA levels and the kinetics in the outcome of chemo-radiotherapy (CRT) in a cohort of 47 patients with locally advanced squamous cell head-neck cancer (SCHNC) treated with definitive chemo-radiotherapy. Results: Increased cfDNA levels after therapy completion (after\/before treatment ratio; A\/B-ratio &gt;1) were found in 26\/47 patients (55.3%). Locally advanced T4-stage was significantly associated with higher cfDNA levels after CRT (3.3 ng\/\u03bcl in T4-stage vs. 1.3 ng\/\u03bcl in T1-3 stages, p=0.007). Patients who responded to CRT (partial\/complete response) had significantly lower cfDNA levels before therapy (mean values 1.2 ng\/\u03bcl vs. 2.7 ng\/\u03bcl, p=0.03). A significantly worse locoregional progression-free survival in patients with an A\/B-ratio &gt;1 was documented (p=0.01; hazard ratio 3.5, 95%CI=1.2-9.7). This was also confirmed in multivariate analysis, where the A\/B-ratio was an independent predictive variable of locoregional relapse (p=0.03, hazard ratio 3.9, 95%CI=1.2-13). Conclusion: High post-CRT cfDNA levels could be an early biomarker for the immediate recruitment of patients with SCHNC in consolidation chemo-immunotherapy protocols.<\/jats:p>","DOI":"10.21873\/cdp.10254","type":"journal-article","created":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T06:56:53Z","timestamp":1693551413000},"page":"551-557","source":"Crossref","is-referenced-by-count":24,"title":["Circulating Plasma Cell-free DNA (cfDNA) as a Predictive Biomarker for Radiotherapy: Results from a Prospective Trial in Head and Neck Cancer"],"prefix":"10.21873","volume":"3","author":[{"given":"MICHAEL I.","family":"KOUKOURAKIS","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ERASMIA","family":"XANTHOPOULOU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"IOANNIS M.","family":"KOUKOURAKIS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SOTIRIOS P.","family":"FORTIS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"NIKOLAOS","family":"KESESIDIS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"IOANNIS","family":"KARAKASILIOTIS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CONSTANTIN N.","family":"BAXEVANIS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"9336","published-online":{"date-parts":[[2023,9,1]]},"container-title":["Cancer Diagnosis &amp; Prognosis"],"original-title":[],"deposited":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T06:57:00Z","timestamp":1693551420000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cancerdiagnosisprognosis.org\/article\/255\/circulating-plasma-cell-free-dna-cfdna-as-a-predictive-biomarker-for-radiotherapy-results-from-a-prospective-trial-in-head-and-neck-cancer"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,1]]},"references-count":0,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,9,1]]},"published-print":{"date-parts":[[2023,9,1]]}},"URL":"https:\/\/doi.org\/10.21873\/cdp.10254","relation":{},"ISSN":["2732-7787"],"issn-type":[{"value":"2732-7787","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,1]]}}}